Cargando…
Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
Autores principales: | Nik, Maryam Ebrahimi, Malaekeh-Nikouei, Bizhan, Amin, Mohamadreza, Hatamipour, Mahdi, Teymouri, Manouchehr, Sadeghnia, Hamid Reza, Iranshahi, Mehrdad, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044310/ https://www.ncbi.nlm.nih.gov/pubmed/32103120 http://dx.doi.org/10.1038/s41598-020-60918-2 |
Ejemplares similares
-
Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2019) -
Interactive anticancer effect of nanomicellar curcumin and galbanic acid combination therapy with some common chemotherapeutics in colon carcinoma cells
por: Jafari, Arash, et al.
Publicado: (2019) -
The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
por: Dadpour, Saba, et al.
Publicado: (2022) -
Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023) -
Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)